-
Baldovin T, Mel R, Bertoncello C, Carpene G, Soppelsa F, Giliberti A, Baldo V, 2012: Persistence of immunity to tick-borne encephalitis after vaccination and natural infection[J]. J Med Virol, 84, 1274-1278. doi: 10.1002/jmv.v84.8
-
Buddhari D, Aldstadt J, Endy TP, Srikiatkhachorn A, Thaisomboonsuk B, Klungthong C, Nisalak A, Khuntirat B, Jarman RG, Fernandez S, Thomas SJ, Scott TW, Rothman AL, Yoon IK, 2014: Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies[J]. PLoS Negl Trop Dis, 8, e3230-. doi: 10.1371/journal.pntd.0003230
-
Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS, 2011: Estimated global incidence of Japanese encephalitis: a systematic review[J]. Bull World Health Organ, 89, 774A-774E.
-
Gao X, Li X, Li M, Fu S, Wang H, Lu Z, Cao Y, He Y, Zhu W, Zhang T, Gould EA, Liang G, 2014: Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011[J]. PLoS Negl Trop Dis, 8, e3015-. doi: 10.1371/journal.pntd.0003015
-
Hegde NR, Gore MM, 2017: Japanese encephalitis vaccines: immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease[J]. Hum Vaccines Immunother, 13, 1-18. doi: 10.1080/21645515.2017.1278976
-
Hombach J, Solomon T, Kurane I, Jacobson J, Wood D, 2005: Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004[J]. Vaccine, 23, 5205-5211. doi: 10.1016/j.vaccine.2005.07.002
-
Hsu LC, Chen YJ, Hsu FK, Huang JH, Chang CM, Chou P, Lin IF, Chang FY, 2014: The incidence of Japanese encephalitis in Taiwan—a population-based study[J]. PLoS Negl Trop Dis, 8, e3030-.
-
Khan SA, Kakati S, Dutta P, Chowdhury P, Borah J, Topno R, Jadhav SM, Mohapatra PK, Mahanta J, Gupte MD, 2016: Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults[J]. Indian J Med Res, 144, 886-892. doi: 10.4103/ijmr.IJMR_712_15
-
Konishi E, Ajiro N, Nukuzuma C, Mason PW, Kurane I, 2003: Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice[J]. Vaccine, 21, 3675-3683. doi: 10.1016/S0264-410X(03)00382-7
-
Konishi E, Kitai Y, Tabei Y, Nishimura K, Harada S, 2010: Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program[J]. Vaccine, 28, 2664-2670. doi: 10.1016/j.vaccine.2010.01.008
-
Lee DW, Choe YJ, Kim JH, Song KM, Cho H, Bae GR, Lee JK, 2012: Epidemiology of Japanese encephalitis in South Korea, 2007-2010[J]. Int J Infect Dis, 16, e448-e452.
-
Lee EY, Kim JY, Lee DK, Yoon IS, Ko HL, Chung JW, Chang J, Nam JH, 2016: Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice[J]. Microbiol Immunol, 60, 846-853. doi: 10.1111/1348-0421.12458
-
Li X, Ma SJ, Liu X, Jiang LN, Zhou JH, Xiong YQ, Ding H, Chen Q, 2014: Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review[J]. Hum Vaccin Immunother, 10, 3579-3593. doi: 10.4161/21645515.2014.980197
-
Li X, Cui S, Gao X, Wang H, Song M, Li M, Fu S, Lv Z, He Y, Lei W, Wang B, Lu X, Liang G, 2016: The spatio-temporal distribution of Japanese encephalitis cases in different age groups in Mainland China, 2004-2014[J]. PLoS Negl Trop Dis, 10, e0004611-. doi: 10.1371/journal.pntd.0004611
-
Liu X, Yu Y, Li M, Liang G, Wang H, Jia L, Dong G, 2011: Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China[J]. Vaccine, 29, 2127-2130. doi: 10.1016/j.vaccine.2010.12.108
-
Luo D, Yin H, Xili L, Song J, Wang Z, 1994: The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study[J]. Southeast Asian J Trop Med Public Health, 25, 643-646.
-
Mansfield KL, Hernandez-Triana LM, Banyard AC, Fooks AR, Johnson N, 2017: Japanese encephalitis virus infection, diagnosis and control in domestic animals[J]. Vet Microbiol, 201, 85-92.
-
Misra UK, Kalita J, 2010: Overview: Japanese encephalitis[J]. Prog Neurobiol, 91, 108-120. doi: 10.1016/j.pneurobio.2010.01.008
-
Monath TP, Fowler E, Johnson CT, Balser J, Morin MJ, Sisti M, Trent DW, 2011: An inactivated cell-culture vaccine against yellow fever[J]. N Engl J Med, 364, 1326-1333. doi: 10.1056/NEJMoa1009303
-
Ohrr H, Tandan JB, Sohn YM, Shin SH, Pradhan DP, Halstead SB, 2005: Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study[J]. Lancet, 366, 1375-1378. doi: 10.1016/S0140-6736(05)67567-8
-
Oya A, 1988: Japanese encephalitis vaccine[J]. Acta Paediatr Jpn, 30, 175-184. doi: 10.1111/ped.1988.30.issue-2
-
Pan JR, Yan JY, Zhou JY, Tang XW, He HQ, Xie RH, Mao HY, Zhang YJ, Xie SY, 2016: Sero-molecular epidemiology of Japanese encephalitis in Zhejiang, an eastern province of China[J]. PLoS Negl Trop Dis, 10, e0004936-. doi: 10.1371/journal.pntd.0004936
-
Saxena V, Dhole TN, 2008: Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India[J]. J Biosci, 33, 505-514.
-
Simon LV, Kruse B (2017) Encephalitis, Japanese. StatPearls, Treasure Island
-
Sirivichayakul C, Sabchareon A, Limkittikul K, Yoksan S, 2014: Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort[J]. Thailand. Virol J, 11, 48-. doi: 10.1186/1743-422X-11-48
-
Sohn YM, Tandan JB, Yoksan S, Ji M, Ohrr H, 2008: A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses[J]. Vaccine, 26, 1638-1643. doi: 10.1016/j.vaccine.2008.01.021
-
Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW, Khanh VT, 2000: Japanese encephalitis[J]. J Neurol Neurosurg Psychiatry, 68, 405-415. doi: 10.1136/jnnp.68.4.405
-
Tandale BV, Khan SA, Kushwaha KP, Rahman H, Gore MM, 2018: Japanese Encephalitis Vaccination Efficacy Case Control Study G (2018) Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: retrospective 1:4 matched case-control study[J]. J Infect Public Health, 11, 713-719. doi: 10.1016/j.jiph.2018.04.011
-
Tseng HF, Tan HF, Chang CK, Huang WL, Ho WC, 2003: Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships[J]. Am J Infect Control, 31, 435-440. doi: 10.1067/mic.2003.73
-
Turtle L, Tatullo F, Bali T, Ravi V, Soni M, Chan S, Chib S, Venkataswamy MM, Fadnis P, Yaich M, Fernandez S, Klenerman P, Satchidanandam V, Solomon T, 2017: Cellular immune responses to live attenuated Japanese encephalitis (JE) vaccine SA14-14-2 in adults in a JE/dengue co-endemic area[J]. PLoS Negl Trop Dis, 11, e0005263-. doi: 10.1371/journal.pntd.0005263
-
Upreti SR, Lindsey NP, Bohara R, Choudhary GR, Shakya S, Gautam M, Giri JN, Fischer M, Hills SL, 2017: Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal[J]. PLoS Negl Trop Dis, 11, e0005866-. doi: 10.1371/journal.pntd.0005866
-
Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S, 2011: Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(R)) induced neutralizing antibody titers[J]. Vaccine, 29, 5925-5931. doi: 10.1016/j.vaccine.2011.06.062
-
Wang H, Liang G, 2015: Epidemiology of Japanese encephalitis: past, present, and future prospects[J]. Ther Clin Risk Manag, 11, 435-448.
-
Wang R, Liao X, Fan D, Wang L, Song J, Feng K, Li M, Wang P, Chen H, An J, 2018: Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice[J]. Vaccine, 36, 3522-3532. doi: 10.1016/j.vaccine.2018.04.051
-
Wu CJ, Huang HW, Tao MH, 2003: Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine[J]. Vaccine, 21, 3938-3945. doi: 10.1016/S0264-410X(03)00277-9
-
Xin YY, Ming ZG, Peng GY, Jian A, Min LH, 1988: Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children[J]. Am J Trop Med Hyg, 39, 214-217. doi: 10.4269/ajtmh.1988.39.214
-
Zhang L, Luan RS, Jiang F, Rui LP, Liu M, Li YX, Yin ZD, Luo HM, 2012: Epidemiological characteristics of Japanese encephalitis in Guizhou Province, China, 1971-2009[J]. Biomed Environ Sci, 25, 297-304.